Profiel
Ronald Bronsaer is the founder.
He founded CellMade SAS in 2007 and currently holds the title of Chairman & Chief Executive Officer.
Prior to founding CellMade SAS, Dr. Bronsaer worked at Cambrex Corp.
from 2000 to 2007, where he held the title of Director-Business Development in 2007.
Actieve functies van Ronald Bronsaer
| Bedrijven | Functie | Begin |
|---|---|---|
CellMade SAS
 CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Algemeen Directeur | 24-06-2009 |
Eerdere bekende functies van Ronald Bronsaer
| Bedrijven | Functie | Einde |
|---|---|---|
| CAMBREX CORPORATION | Corporate Officer/Principal | 01-01-2007 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
CellMade SAS
CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Health Technology |
